As of April 2024 Evoke Pharma has a market cap of $4.65 Million. This makes Evoke Pharma the world's 8248th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $4.65 M | 32.56% |
2023 | $3.51 M | -60.81% |
2022 | $8.95 M | -50.12% |
2021 | $17.96 M | -73.62% |
2020 | $68.08 M | 72.02% |
2019 | $39.57 M | -8.42% |
2018 | $43.22 M | 24.07% |
2017 | $34.83 M | 39.63% |
2016 | $24.94 M | 4.97% |
2015 | $23.76 M | -34.1% |
2014 | $36.06 M | -20.61% |
2013 | $45.42 M |
On Apr 17th, 2024 the market cap of Evoke Pharma was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
ANI Pharmaceuticals ANIP | $1.37 B | 29,416.50% | ๐บ๐ธ USA |
Amphastar Pharmaceuticals AMPH | $1.95 B | 41,948.73% | ๐บ๐ธ USA |
Aerie Pharmaceuticals AERI | $0.75 B | 16,091.77% | ๐บ๐ธ USA |
Ironwood Pharmaceuticals
IRWD | $1.19 B | 25,627.69% | ๐บ๐ธ USA |